Cargando…
Maintenance Chemotherapy Use for Advanced Non-Small Cell Lung Cancer in an Australian Cancer Centre
BACKGROUND: To investigate the rates of maintenance therapy in advanced non-small cell cancer, the reasons for not progressing to second line therapy at disease progression at our cancer centre and to use this data as a way to institute it into clinical practice in our cancer centre. METHOD: This st...
Autores principales: | Wann, Alysson, Newnham, Genni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649804/ https://www.ncbi.nlm.nih.gov/pubmed/29147317 http://dx.doi.org/10.4021/wjon590w |
Ejemplares similares
-
High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer
por: Krypuy, Michael, et al.
Publicado: (2006) -
Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre
por: Nguyen, Mike, et al.
Publicado: (2020) -
Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer
por: Newnham, Genni M, et al.
Publicado: (2011) -
Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting
por: Li, Jianjie, et al.
Publicado: (2021) -
Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status
por: Jian, Hong, et al.
Publicado: (2017)